AMGN CIK: 318154

Amgen Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
19.5
FY22:
19.9
FY23:
19.7
FY24:
20.6
FY25:
24.7
(positive)
Change from FY21 to FY25
billions USD
FY21:
7.64
FY22:
9.57
FY23:
7.90
FY24:
7.26
FY25:
9.08
(positive)
Change from FY22 to FY25
billions USD
FY21:
–
FY22:
12.2
FY23:
14.8
FY24:
13.4
FY25:
16.9
(positive)
Change from FY21 to FY25
billions USD
FY21:
6.70
FY22:
7.35
FY23:
7.86
FY24:
4.61
FY25:
8.98
(positive)
Change from FY21 to FY25
billions USD
FY21:
5.89
FY22:
6.55
FY23:
6.72
FY24:
4.09
FY25:
7.71

All amounts in billions USD Data sources:SEC EDGARTwelve Data